Page last updated: 2024-08-23

sodium azide and neuropeptide y

sodium azide has been researched along with neuropeptide y in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beal, MF; Brouillet, E; Henshaw, DR; Hyman, BT; Jenkins, BG; Rosen, BR; Schulz, JB; Sodhi, P	1
Biber, K; Boddeke, HW; Brouwer, N; de Jong, EK; Eisel, UL; Granic, I; Liem, RS; Stanulovic, V; Vinet, J	1

Other Studies

2 other study(ies) available for sodium azide and neuropeptide y

Article	Year
Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism. Experimental neurology, 1994, Volume: 129, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Aging; Animals; Azides; Biogenic Amines; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Functional Laterality; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Homovanillic Acid; Injections, Intraperitoneal; Lactates; Magnetic Resonance Imaging; Male; Microinjections; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Neuropeptides; Neurotoxins; Oxidative Phosphorylation; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sodium Azide; Somatostatin; Substance P	1994
Expression of CXCL10 in cultured cortical neurons. Journal of neurochemistry, 2010, Volume: 112, Issue:3 Topics: Amyloid beta-Peptides; Animals; CD11b Antigen; Cells, Cultured; Cerebral Cortex; Chemokine CXCL10; Coculture Techniques; Embryo, Mammalian; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation; Gene Expression Regulation, Developmental; Glial Fibrillary Acidic Protein; Glioma; Glutamic Acid; Green Fluorescent Proteins; Humans; Immunoprecipitation; Lipopolysaccharides; Mice; Microscopy, Immunoelectron; Neuroblastoma; Neuroglia; Neurons; Neuropeptide Y; Peptide Fragments; RNA, Messenger; Sodium Azide; Sodium Chloride; Synaptic Vesicles; Time Factors; Transfection; Vesicle-Associated Membrane Protein 2	2010

Article

Year

Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.

Experimental neurology, 1994, Volume: 129, Issue:2

Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Aging; Animals; Azides; Biogenic Amines; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Functional Laterality; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Homovanillic Acid; Injections, Intraperitoneal; Lactates; Magnetic Resonance Imaging; Male; Microinjections; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Neuropeptides; Neurotoxins; Oxidative Phosphorylation; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sodium Azide; Somatostatin; Substance P

1994

Expression of CXCL10 in cultured cortical neurons.

Journal of neurochemistry, 2010, Volume: 112, Issue:3

Topics: Amyloid beta-Peptides; Animals; CD11b Antigen; Cells, Cultured; Cerebral Cortex; Chemokine CXCL10; Coculture Techniques; Embryo, Mammalian; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation; Gene Expression Regulation, Developmental; Glial Fibrillary Acidic Protein; Glioma; Glutamic Acid; Green Fluorescent Proteins; Humans; Immunoprecipitation; Lipopolysaccharides; Mice; Microscopy, Immunoelectron; Neuroblastoma; Neuroglia; Neurons; Neuropeptide Y; Peptide Fragments; RNA, Messenger; Sodium Azide; Sodium Chloride; Synaptic Vesicles; Time Factors; Transfection; Vesicle-Associated Membrane Protein 2

2010